First Reported Case of Oral Ulceration Induced by Improper Sodium Ibandronate Administration in a Geriatric Patient

The prevalence of osteoporosis is increasing, and bisphosphonate (BP) medications are widely used for its treatment. Oral BP drugs carry the risk of esophageal ulcers, which can be mitigated by following the proper administration guidelines. However, cases of oral ulceration caused by misuse, such as chewing of tablets predominantly comprising alendronate sodium, have been reported globally. Herein, we report the first case of oral ulceration attributed to the misuse of sodium ibandronate.